Lasa Supergenerics Ltd.
| BSE: 540702 | Sector: Health care |
| NSE: LASA | ISIN Code: INE670X01014 |
| BSE 00:00 | 25 Jan | 84.20 |
-2.90 (-3.33%) |
OPEN
87.10 |
HIGH
89.45 |
LOW
84.00 |
| NSE 00:00 | 25 Jan | 84.45 |
-2.80 (-3.21%) |
OPEN
88.50 |
HIGH
89.15 |
LOW
84.00 |
| OPEN | 87.10 |
| PREVIOUS CLOSE | 87.10 |
| VOLUME | 6268 |
| 52-Week high | 100.15 |
| 52-Week low | 26.00 |
| P/E | 19.49 |
| Mkt Cap.(Rs cr) | 342 |
| Buy Price | 84.20 |
| Buy Qty | 250.00 |
| Sell Price | 85.00 |
| Sell Qty | 598.00 |
Lasa Supergenerics Ltd. (LASA) - News Sector
-
Apollo Hospitals gains 4%, hits new high on successful fund raising via QIP
1.59 pm | 25 Jan 2021 | Business Standard
Apollo Hospitals said it will use the funds raised to acquire a 50 per cent stake in a joint venture, seek inorganic growth opportunities, as well as,...
-
Aurobindo gains 5% on govt nod for promotion of manufacturing bulk drugs
10.46 am | 25 Jan 2021 | Business Standard
Aurobindo Pharma (through Lyfius Pharma) has received government approval for setting up plants for production of Penicillin-G and 7-ACA, under the PL...
-
Biocon stock slides on poor Q3 results, exit of biologics arm's MD
12.44 am | 23 Jan 2021 | Business Standard
From its previous close of Rs 441.95 apiece on Thursday, the stock closed 10.89 per cent or Rs 48.15 lower at Rs 393.80, on Friday
-
Market reacts negatively to Biocon's weaker results, exit of biologics' MD
1.15 pm | 22 Jan 2021 | Business Standard
Analysts have raised doubts over the $1 billion guidance for biosimilars by FY22 and Hamacher's exit due to "professional differences"
-
SBI, ITC, Titan: Over 50% of Sensex constituents look weak on charts
12.57 pm | 22 Jan 2021 | Business Standard
Technical indicators show that Bharti Airtel, Sun Pharmaceutical Industries, and ONGC are not showing an optimistic view from a short-term perspective
-
SBI, ITC, Titan: Over 50% of Sensex constituents look weak on charts
12.57 pm | 22 Jan 2021 | Business Standard
Technical indicators show that Bharti Airtel, Sun Pharmaceutical Industries, and ONGC are not showing an optimistic view from a short-term perspective
-
Biocon tanks 10% on lower-than-expected December quarter results
10.26 am | 22 Jan 2021 | Business Standard
Due to professional differences with the chairperson on strategic priorities and the vision for the company, Dr Christiane Hamacher has stepped down a...
-
Biocon posts 19% dip in Q3 net profit as generics biz takes a hit
1.00 am | 22 Jan 2021 | Business Standard
Biocon's consolidated revenue for Q3 of FY21 increased by 7.20 per cent at Rs 1878.9 crore as against Rs 1752.6 crore for the said quarter last year
-
Alembic Pharma extends decline on mixed December quarter results
10.25 am | 20 Jan 2021 | Business Standard
Motilal Oswal Securities said Alembic Pharma missed Q3FY21 earnings estimate, weighed by lower-than-expected sales in the US
-
Apollo Hospitals hits record high on launch of Rs 1,000-crore QIP
3.14 pm | 19 Jan 2021 | Business Standard
The final issue price, including any discount to the floor price, will be determined in the fund-raising committee meeting on January 22, 2021
-
Piramal Enterprises: DHFL acquisition fast-forwards retail aspiration
11.36 pm | 18 Jan 2021 | Business Standard
Integration may take about six months, though execution may be a tightrope walk
-
New product launches to drive growth for Lupin, US business a key trigger
9.36 pm | 18 Jan 2021 | Business Standard
This should reverse the US underperformance in FY15-20 with margins too moving up sharply
-
Apollo Hospitals opens QIP with floor price of Rs 2,508.58 a share
8.11 pm | 18 Jan 2021 | Business Standard
Sources said that the hospital chain is targeting large Domestic Mutual Funds, Sovereign Funds
-
Metropolis Healthcare to acquire Chennai-based diagnostic lab for Rs 511 cr
9.31 am | 18 Jan 2021 | Business Standard
Metropolis will acquire 100 per cent equity of Dr Ganesan's Hitech Diagnostic Centre in a cash and stock deal
-
Stocks to watch: HDFC Bank, Metropolis Healthcare, Wipro, Airtel, DHFL
8.48 am | 18 Jan 2021 | Business Standard
Metropolis Healthcare said it will acquire Dr Ganesan's Hitech Diagnostic Centre
-
Here is a derivative strategy for Cadila Health by Vinay Rajani of HDFC Sec
7.22 am | 15 Jan 2021 | Business Standard
The stock price of Cadila Healthcare has broken out from the consolidation which held for last three weeks
-
Select pharma shares rally; Suven Pharma up 13%, Laurus nears record high
1.44 pm | 14 Jan 2021 | Business Standard
Healthcare companies to post decent growth in revenues in Q3FY21
-
Select pharma shares rally; Suven Pharma up 13%, Laurus nears record high
1.44 pm | 14 Jan 2021 | Business Standard
Healthcare companies to post decent growth in revenues in Q3FY21
-
Select pharma shares rally; Suven Pharma up 13%, Laurus nears record high
1.44 pm | 14 Jan 2021 | Business Standard
Healthcare companies to post decent growth in revenues in Q3FY21
-
Select pharma shares rally; Suven Pharma up 13%, Laurus nears record high
1.44 pm | 14 Jan 2021 | Business Standard
Healthcare companies to post decent growth in revenues in Q3FY21
Quick Links for Lasa Supergenerics:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
